Company Overview

Intuitive Surgical, Inc. is a medical technology company focused on the development, manufacturing, and commercialization of robotic-assisted surgical systems. The company operates primarily within the medical devices and minimally invasive surgery industries, with its technology designed to enhance clinical outcomes through improved precision, dexterity, and visualization. Its business is centered on enabling surgeons to perform complex procedures using robotic assistance rather than open or conventional laparoscopic approaches.

The company’s core revenue drivers include sales of its da Vinci Surgical Systems, recurring revenue from Instruments & Accessories, and ongoing Services contracts. Intuitive Surgical primarily serves hospitals, health systems, and surgical centers across multiple specialties, including urology, gynecology, general surgery, thoracic surgery, and colorectal procedures. Founded in 1995 and publicly listed in 2000, the company has evolved from an early-stage robotics innovator into a dominant player in robotic-assisted surgery with a large installed base and recurring revenue model that reinforces long-term customer relationships.

Business Operations

Intuitive Surgical operates through three primary business segments: Systems, Instruments & Accessories, and Services. The Systems segment includes the sale of robotic surgical platforms, most notably the da Vinci family of systems and the Ion endoluminal robotic platform. The Instruments & Accessories segment generates recurring revenue through the sale of disposable and limited-use instruments used during each surgical procedure. The Services segment includes maintenance contracts, training, and system upgrades, providing predictable and recurring cash flows.

Operations are conducted globally, with manufacturing, engineering, and product development largely based in the United States, supported by international sales and service organizations. The company controls proprietary robotic technologies, software, visualization systems, and surgeon training programs. Intuitive Surgical operates primarily through wholly owned subsidiaries and does not rely heavily on joint ventures, maintaining tight control over its technology stack and commercialization strategy.

Strategic Position & Investments

Intuitive Surgical’s strategy emphasizes expanding procedure adoption, increasing utilization of its installed base, and developing next-generation robotic platforms and digital capabilities. Growth initiatives focus on expanding into new surgical indications, enhancing surgeon training, and improving workflow efficiency through system upgrades and data-enabled insights. The company continues to invest heavily in research and development to maintain technological leadership and defend its competitive moat.

Strategic investments include continued development of the Ion robotic system for minimally invasive lung biopsy procedures and iterative advancements to the da Vinci platform. Intuitive Surgical has historically favored organic growth over large acquisitions, selectively acquiring complementary technologies to support core platforms. The company’s emerging focus areas include advanced imaging, artificial intelligence–assisted surgical planning, and data analytics to support clinical decision-making and procedural standardization.

Geographic Footprint

Intuitive Surgical is headquartered in North America, with its principal executive offices in Sunnyvale, California. The company has a significant presence across Europe, Asia-Pacific, and other international markets, supporting a broad and diversified global customer base. The United States remains its largest single market by revenue, driven by a high concentration of robotic-assisted surgical procedures.

Internationally, the company maintains sales, training, and service operations across Western Europe, Japan, China, and other parts of Asia, as well as select markets in Latin America and the Middle East. Its global footprint supports both system placements and recurring procedural revenue, with international markets representing a growing share of total procedures and long-term growth opportunities.

Leadership & Governance

Intuitive Surgical was co-founded by Frederic H. Moll � Founder, who played a foundational role in shaping the company’s early vision for robotic-assisted surgery. The current leadership team emphasizes disciplined innovation, clinical evidence generation, and long-term value creation rather than short-term market expansion.

Key members of the executive leadership team include:

• Gary S. Guthart � Chief Executive Officer
• Jamie Samath � Chief Financial Officer
• Myriam Curet � Executive Vice President and Chief Medical Officer
• Dave Rosa � Executive Vice President and Chief Strategy and Growth Officer

The leadership philosophy centers on surgeon-led innovation, rigorous clinical validation, and maintaining high regulatory and quality standards. Governance practices are aligned with long-term shareholder interests, supported by a board with experience across healthcare, technology, and global operations.